当前位置：首页 > 文献互助 > 互助详情

Setidegrasib in Advanced Non–Small-Cell Lung Cancer and Pancreatic Cancer复制

用户EO9nReo4Hj6s 1小时前 5 10 求助中 帖子自动结束时间: 2026-04-27 11:27:12

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1056/nejmoa2600752复制

文献链接: http://www.nejm.org/doi/10.1056/NEJMoa2600752复制

其他信息:

出版社: Massachusetts Medical Society
作者: Wungki Park; Anup Kasi; Alexander I. Spira; Luis Paz-Ares Rodríguez; Benjamin O. Herzberg; Meredith S. Pelster; Anthony W. Tolcher; Yasutoshi Kuboki; Shigehisa Kitano; Hirokazu Shoji; Judy S. Wang; Jordan D. Berlin; Antoine Hollebecque; Patricia LoRusso; Christos Fountzilas; Philippe A. Cassier; Tomohiro Nishina; Daisuke Sakai; Chiaki Inagaki; Daniel Morgensztern; Makoto Ueno; Minkyu Jung; Sang-We Kim; Pasi A. Jänne; Antoine Italiano; Benoît You; T Macarulla; Hisaki Fujii; Aditya Shetty; Ying Lu; Daniel Cui; Shilpa Kadam; Stanley C. Gill; Junko Toyoshima; Takeshi Saito; Jonathan W. Goldman

上一篇：Survival outcome of VATS compared with open lobectomy for lung cancer: an individual patient data meta-analysis of randomised trials

下一篇：Fulzerasib plus cetuximab in first-line KRAS-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial

互助时间线

2026-04-22 11:27:12 [发起求助]

最新发布的求助

Yanxiao Di’naer decoction attenuates metabolic dysfunction-associated steatohepatitis through the regulation of gut microbiota and the metabolism of bile acid 32分钟前
Tangeretin formulated in a self-nano-emulsifying drug-delivery system (SNEDDS) alleviates symptoms of rheumatoid arthritis by antagonizing M1 macrophages polarization 1小时前
Prevention and treatment of inflammatory arthritis with traditional Chinese medicine: Underlying mechanisms based on cell and molecular targets 1小时前
Prevention and treatment of inflammatory arthritis with traditional Chinese medicine: Underlying mechanisms based on cell and molecular targets 1小时前
Updates on the Perioperative Management of Resectable Non–Small Cell Lung Cancer 1小时前
HSR26-260: Comparative Efficacy and Safety of Second-Line Therapies in Relapsed Small-Cell Lung Cancer: A Systematic Review and Pooled Analysis 1小时前
Model-based dose selection for phase 3 trials of the selective P2X3 antagonist camlipixant in refractory chronic cough 1小时前
Antibody–Drug Conjugates in Small-Cell Lung Cancer: DLL3, B7-H3, TROP2 and Beyond 1小时前
Benmelstobart plus anlotinib versus pembrolizumab as first-line treatment for PD-L1-positive, advanced non-small-cell lung cancer (CAMPASS): a blinded, randomised, controlled, phase 3 trial 1小时前
Fulzerasib plus cetuximab in first-line KRAS-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial 1小时前
Setidegrasib in Advanced Non–Small-Cell Lung Cancer and Pancreatic Cancer 1小时前
Survival outcome of VATS compared with open lobectomy for lung cancer: an individual patient data meta-analysis of randomised trials 1小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com